SPACs’ Painful Reckoning Should Not Spell Their Demise: Op/Ed

spac

Sooner or later SPACs were going to face a painful realignment, Caixin Global writes. Once shining brighter than a white-hot star, these shells or blank-check companies, have rapidly dimmed, losing major wattage. Their basic premise — permitting access to early-stage, private companies, from which retail investors are normally excluded — is admirable and much-needed in a market that all too often favors institutional players.

But over the past two years, SPAC sponsors, target companies, consultants, auditors and lawyers, among others have been drawn into a swirling vortex that, at times, has degenerated into a free-for-all, amplifying echoes and drawing unfavorable comparisons of market exuberance from the South Sea bubble of the 18th century to the dot-com bubble of 2001.

On the whole, a SPAC’s lower cost and shorter timeframe to a public listing compared to traditional IPOs have won many admirers. Equally noteworthy, some acquisition targets could commandeer a higher price via a SPAC merger than through the private markets. But gale force winds — including a series of scandals, disappointing performance amid a tumbling stock market and heightened regulatory focus — have blown off the euphoric bubbly froth that has soaked the SPAC market during the past two years. Read more.

Total
0
Shares
Related Posts
CFIUS
Read More

SPACs and CFIUS: Due Diligence Considerations

SPAC investors and target businesses in other countries can raise national security and regulatory considerations, and in particular, the attention of foreign investment review mechanisms such as the Committee on Foreign Investment in the United States (CFIUS) and similar regimes in other countries, writes risk compliance and monitoring firm K2 Integrity.